GEMOPHENIX device (AMPld-"TT")
Intended use
Device AMPld-"TT" (trademark "GEMOPHENIX") for therapeutic and/or donor membrane plasmapheresis.
The continuous membrane plasmapheresis process on the GEMOPHENIX device is performed using a single-needle system in a single-use sterile extracorporeal circuit. During the procedure, formed elements are returned to the patient's bloodstream, plasma is collected in a special receiver, and plasma replacement is carried out. Donor plasma obtained on the GEMOPHENIX device and the Rosa plasma filter meets the regulatory requirements of the Blood Service.
An optimal price-to-quality ratio makes the GEMOPHENIX device accessible for equipping small medical facilities and blood transfusion departments.
Main specifications
- Blood flow rate up to 100 ml/min;
- Volume of plasma obtained at least 0.8 l/hour;
- Dosed delivery of anticoagulant;
- Continuous operating time up to 10 hours;
- Weight less than 15 kg;
- Dimensions 450×320×120 mm;
- Power consumption not more than 70 W;
- Automatic operating mode and electronic self-diagnostics.
Delivery form
The device is supplied with disposable consumable sets, including Rosa plasma filters, blood-conducting lines, and infusion solutions.
Documentation
TRACKPORE TECHNOLOGIES holds all the necessary certificates and Russian Federation permits for its products, and has ISO 9001 and ISO 13485 quality management system certificates. The medical equipment manufactured by the company has passed European quality review and received CE certification.